New Enterprise Associates 14, L.P. is > 10% Shareholder of Oyster Point Pharma, Inc.. Currently has a direct ownership of 0 shares of OYST, which is worth approximately $0. The most recent transaction as insider was on Jan 03, 2023, when has been sold 5,925,287 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

New Enterprise Associates 14, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2023
SELL
Disposition due to a tender of shares in a change of control transaction
-
5,925,287 Reduced 100.0%
0 Common Stock

Also insider at

IMRA
IMARA Inc. Healthcare
LNFA-WT
L&F Acquisition Corp.
NEA

New Enterprise Associates 14, L.P.

> 10% Shareholder
Timonium, MD

Track Institutional and Insider Activities on OYST

Follow Oyster Point Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OYST shares.

Notify only if

Insider Trading

Get notified when an Oyster Point Pharma, Inc. insider buys or sells OYST shares.

Notify only if

News

Receive news related to Oyster Point Pharma, Inc.

Track Activities on OYST